MVK

UniProt ID: Q03426
Organism: Homo sapiens
Review Status: INITIALIZED
πŸ“ Provide Detailed Feedback

Gene Description

MVK encodes mevalonate kinase (MK; EC 2.7.1.36), a GHMP-kinase-family enzyme that catalyses the ATP-dependent, Mg2+-requiring phosphorylation of (R)-mevalonate to (R)-5-phosphomevalonate. This is the committed step immediately downstream of HMG-CoA reductase in the cytosolic mevalonate/isoprenoid pathway, feeding synthesis of isopentenyl diphosphate, farnesyl and geranylgeranyl diphosphate, dolichol, ubiquinone and cholesterol. The enzyme is a homodimer, requires Mg2+, and is subject to competitive feedback inhibition at its ATP-binding site by farnesyl and geranylgeranyl diphosphate, making it a key regulatory node of the pathway. Human MK is a cytosolic enzyme (with a minor/disputed peroxisomal pool inferred by similarity). Loss-of-function variants cause mevalonate kinase deficiency, a clinical spectrum ranging from the milder hyperimmunoglobulinaemia D and periodic fever syndrome (HIDS) to severe mevalonic aciduria (developmental delay, dysmorphic features, and recurrent febrile crises); MVK variants are also associated with porokeratosis.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0004496 mevalonate kinase activity
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetically-inferred core molecular function. Mevalonate kinase activity is the defining, experimentally established activity of this protein.
Reason: This is the well-characterized core catalytic function, directly demonstrated for the human enzyme by kinetics and mutagenesis, and supported by orthologs across the PANTHER family.
Supporting Evidence:
PMID:9325256
cDNA encoding human mevalonate kinase has been overexpressed and the recombinant enzyme isolated. This stable enzyme is a dimer of 42-kDa subunits
GO:0005829 cytosol
IBA
GO_REF:0000033
ACCEPT
Summary: Cytosolic localization, confirmed directly for the human enzyme by multiple biochemical and microscopy methods.
Reason: Human MK was shown to be exclusively cytosolic; the IBA cytosol call is consistent with the direct experimental data (PMID:14730012).
Supporting Evidence:
PMID:14730012
We exclusively found a cytosolic localisation of both endogenous human MK
GO:0006695 cholesterol biosynthetic process
IBA
GO_REF:0000033
KEEP AS NON CORE
Summary: MK catalyses an early committed step of the mevalonate pathway that ultimately supplies cholesterol biosynthesis.
Reason: Cholesterol biosynthesis is a valid downstream process, but it is one of several branch outputs (dolichol, ubiquinone, prenylation, isoprenoids) of the mevalonate pathway. The more precise, non-branch-committed process is isopentenyl diphosphate biosynthesis via the mevalonate pathway (GO:0019287), captured as core below; cholesterol biosynthesis is kept as a legitimate but non-core downstream role.
Supporting Evidence:
PMID:1377680
Mevalonic aciduria is the first proposed inherited disorder of the
GO:0019287 isopentenyl diphosphate biosynthetic process, mevalonate pathway
IBA
GO_REF:0000033
ACCEPT
Summary: MK catalyses step 1 of the three-step conversion of (R)-mevalonate to isopentenyl diphosphate in the mevalonate pathway; this is the most precise biological process for the enzyme.
Reason: This is the pathway step directly downstream of HMG-CoA reductase and matches UniProt's PATHWAY statement (isopentenyl diphosphate from (R)-mevalonate: step 1/3). Core biological process.
Supporting Evidence:
PMID:18302342
catalyzes a key reaction in polyisoprenoid and
GO:0004496 mevalonate kinase activity
IEA
GO_REF:0000120
ACCEPT
Summary: Electronic assignment of the core mevalonate kinase activity (ARBA/InterPro, EC 2.7.1.36, RHEA:17065).
Reason: Consistent with the experimentally verified core activity; IEA mapping to the correct EC/RHEA reaction.
Supporting Evidence:
file:human/MVK/MVK-uniprot.txt
Reaction=(R)-mevalonate + ATP = (R)-5-phosphomevalonate + ADP + H(+)
GO:0005524 ATP binding
IEA
GO_REF:0000002
ACCEPT
Summary: ATP is the phosphate donor for the kinase reaction; ATP binding is a direct molecular activity supported by kinetics, mutagenesis and the crystal structure.
Reason: MK binds Mg-ATP as co-substrate (KM(ATP) measured; ATP-binding residues mapped). InterPro-based ATP-binding IEA is correct and biologically supported.
Supporting Evidence:
file:human/MVK/MVK-uniprot.txt
KM=74 uM for ATP
GO:0005737 cytoplasm
IEA
GO_REF:0000120
ACCEPT
Summary: Cytoplasmic localization (parent of cytosol); consistent with the direct cytosolic evidence for human MK.
Reason: Correct but less specific than the experimentally supported cytosol term; retained as a valid broader location.
Supporting Evidence:
PMID:14730012
We exclusively found a cytosolic localisation of both endogenous human MK
GO:0008299 isoprenoid biosynthetic process
IEA
GO_REF:0000120
ACCEPT
Summary: MK acts within the mevalonate arm of isoprenoid biosynthesis; a valid but broad biological process.
Reason: Correct parent process; the more specific GO:0019287 (isopentenyl diphosphate biosynthesis, mevalonate pathway) is preferred as core, but this broader term is not wrong.
Supporting Evidence:
PMID:14680974
cholesterol/isoprenoid biosynthetic
GO:0016125 sterol metabolic process
IEA
GO_REF:0000117
KEEP AS NON CORE
Summary: MK contributes to sterol (cholesterol) metabolism as an upstream pathway enzyme.
Reason: Sterol metabolic process is a broad downstream grouping; the enzyme's committed step is upstream of the sterol branch point. Valid but not the core process; the isoprenoid-diphosphate process is more precise.
Supporting Evidence:
file:human/MVK/MVK-uniprot.txt
Cholesterol metabolism
GO:0005515 protein binding
IPI
PMID:21044950
Genome-wide YFP fluorescence complementation screen identifi...
MARK AS OVER ANNOTATED
Summary: Bare protein-binding IPI from a large-scale YFP protein-complementation screen (interaction with POT1/Q9NUX5).
Reason: GO:0005515 "protein binding" is uninformative and conveys nothing about molecular function. The interaction derives from a proteome-wide telomere regulator screen with no evidence for a specific, biologically meaningful MK function. Per curation policy this IPI is retained but flagged as over-annotated rather than removed.
Supporting Evidence:
PMID:21044950
a large-scale screen for regulators of telomeres
GO:0005515 protein binding
IPI
PMID:32296183
A reference map of the human binary protein interactome.
MARK AS OVER ANNOTATED
Summary: Bare protein-binding IPI from a systematic binary interactome map (interaction with RNF141/Q8WVD5).
Reason: GO:0005515 is an uninformative molecular-function term derived from a proteome-scale yeast two-hybrid map; no specific functional role is implied. Retained but flagged as over-annotated.
Supporting Evidence:
PMID:32296183
A reference map of the human binary protein interactome
GO:0042802 identical protein binding
IPI
PMID:16189514
Towards a proteome-scale map of the human protein-protein in...
ACCEPT
Summary: Self-interaction (Q03426–Q03426), consistent with the enzyme being a homodimer.
Reason: Unlike bare protein binding, identical protein binding is informative here and matches the biochemically established homodimeric quaternary structure of MK (PMID:9325256; UniProt SUBUNIT Homodimer).
Supporting Evidence:
PMID:9325256
This stable enzyme is a dimer of 42-kDa subunits
GO:0042802 identical protein binding
IPI
PMID:25502805
A massively parallel pipeline to clone DNA variants and exam...
ACCEPT
Summary: Self-interaction detected in a high-throughput variant-clone interactome pipeline; consistent with homodimerization.
Reason: Corroborates the homodimeric state of MK; informative self-association term.
Supporting Evidence:
PMID:9325256
This stable enzyme is a dimer of 42-kDa subunits
GO:0042802 identical protein binding
IPI
PMID:26871637
Widespread Expansion of Protein Interaction Capabilities by ...
ACCEPT
Summary: Self-interaction from an alternative-splicing interactome study; consistent with homodimerization.
Reason: Corroborates MK homodimer formation.
Supporting Evidence:
PMID:9325256
This stable enzyme is a dimer of 42-kDa subunits
GO:0042802 identical protein binding
IPI
PMID:31515488
Extensive disruption of protein interactions by genetic vari...
ACCEPT
Summary: Self-interaction from a population-variant interaction-disruption study; consistent with homodimerization.
Reason: Corroborates MK homodimer formation.
Supporting Evidence:
PMID:9325256
This stable enzyme is a dimer of 42-kDa subunits
GO:0042802 identical protein binding
IPI
PMID:32296183
A reference map of the human binary protein interactome.
ACCEPT
Summary: Self-interaction (Q03426–Q03426) in the HuRI binary interactome; consistent with homodimerization.
Reason: Corroborates MK homodimer formation; informative self-association term.
Supporting Evidence:
PMID:9325256
This stable enzyme is a dimer of 42-kDa subunits
GO:0019287 isopentenyl diphosphate biosynthetic process, mevalonate pathway
IEA
GO_REF:0000041
ACCEPT
Summary: UniPathway-based electronic assignment of the mevalonate-pathway isopentenyl diphosphate biosynthetic process.
Reason: Matches the UniProt PATHWAY statement (step 1/3, isopentenyl diphosphate from (R)-mevalonate); duplicate of the IBA core BP call and equally valid.
Supporting Evidence:
file:human/MVK/MVK-uniprot.txt
isopentenyl diphosphate from (R)-mevalonate
GO:0005829 cytosol
IDA
GO_REF:0000052
ACCEPT
Summary: Immunofluorescence (HPA) supports cytosolic localization.
Reason: Consistent with the definitive human cytosolic localization data (PMID:14730012).
Supporting Evidence:
PMID:14730012
We exclusively found a cytosolic localisation of both endogenous human MK
GO:0004496 mevalonate kinase activity
EXP
PMID:11278915
Investigation of invariant serine/threonine residues in meva...
ACCEPT
Summary: Experimentally verified mevalonate kinase activity via mutagenesis of invariant serine/threonine residues affecting KM(mevalonate) and Vmax.
Reason: Direct experimental characterization of the human enzyme's kinase activity, including the catalytic Ser-146 and the disease-relevant T243.
Supporting Evidence:
PMID:11278915
V(max) for S146A is diminished by 4000-fold
GO:0004496 mevalonate kinase activity
EXP
PMID:9392419
Post-translational regulation of mevalonate kinase by interm...
ACCEPT
Summary: Experimentally verified mevalonate kinase activity; recombinant human MK assayed and shown to be feedback-inhibited at the ATP site.
Reason: Direct enzymatic assay of human MK confirms the core catalytic activity and its competitive inhibition by isoprenoid diphosphates.
Supporting Evidence:
PMID:9392419
only MKase was inhibited through competitive interaction at the ATP-binding site
GO:0005737 cytoplasm
EXP
PMID:14730012
Mevalonate kinase is a cytosolic enzyme in humans.
ACCEPT
Summary: Experimental subcellular localization: human MK is cytoplasmic/cytosolic.
Reason: Direct experimental evidence (fractionation, digitonin permeabilization, immunofluorescence, immunocytochemistry) for cytoplasmic localization.
Supporting Evidence:
PMID:14730012
We exclusively found a cytosolic localisation of both endogenous human MK
GO:0005777 peroxisome
ISS
GO_REF:0000024
REMOVE
Summary: Peroxisomal localization transferred by similarity from rat P17256.
Reason: This ISS is contradicted by direct experimental evidence in human: MK is exclusively cytosolic with no peroxisomal signal (PMID:14730012), and the same negation is explicitly recorded as a NOT|located_in peroxisome IDA in this GOA. Peroxisome-independent activity of the pathway enzymes was also shown (PMID:14680974). The similarity-based transfer is a demonstrably wrong inference for the human protein.
Supporting Evidence:
PMID:14730012
No indication of a peroxisomal localisation was obtained
GO:0000287 magnesium ion binding
ISS
GO_REF:0000024
ACCEPT
Summary: Mg2+ binding, required cofactor for the kinase reaction (Mg-ATP), mapped to binding residues by similarity.
Reason: MK requires Mg2+ as cofactor and Mg2+-liganding residues (Ser-146, Glu-193) are supported by human mutagenesis; the ISS Mg-binding call is biologically correct.
Supporting Evidence:
file:human/MVK/MVK-uniprot.txt
Name=Mg(2+); Xref=ChEBI:CHEBI:18420
GO:0004496 mevalonate kinase activity
IDA
PMID:18302342
Biochemical and structural basis for feedback inhibition of ...
ACCEPT
Summary: Direct assay and crystal structure (PDB 2R3V) of human MK, confirming kinase activity and defining feedback inhibition by farnesyl thiodiphosphate.
Reason: Structural/biochemical demonstration of the core catalytic activity and its regulation.
Supporting Evidence:
PMID:18302342
Farnesyl thiodiphosphate competes
GO:0005524 ATP binding
ISS
GO_REF:0000024
ACCEPT
Summary: ATP binding transferred by similarity; ATP is the phosphate donor for the kinase reaction.
Reason: Correct and directly supported by human kinetics and structure (KM(ATP), competitive feedback inhibition at the ATP site).
Supporting Evidence:
file:human/MVK/MVK-uniprot.txt
KM=74 uM for ATP
GO:0004496 mevalonate kinase activity
IDA
PMID:9325256
Identification of catalytic residues in human mevalonate kin...
ACCEPT
Summary: Direct assay of recombinant human MK; catalytic residues (Asp-204 base; Glu-193) identified by mutagenesis.
Reason: Foundational direct characterization of the human enzyme's core kinase activity and catalytic mechanism.
Supporting Evidence:
PMID:9325256
support assignment of a crucial catalytic role to
GO:0042802 identical protein binding
IDA
PMID:9325256
Identification of catalytic residues in human mevalonate kin...
ACCEPT
Summary: Homodimerization directly demonstrated: MK is a dimer of 42-kDa subunits.
Reason: Informative self-association term directly supported by the biochemical demonstration that the enzyme is a homodimer.
Supporting Evidence:
PMID:9325256
This stable enzyme is a dimer of 42-kDa subunits
GO:0005829 cytosol
TAS
Reactome:R-HSA-1655846
ACCEPT
Summary: Reactome curator assertion of cytosolic localization.
Reason: Consistent with the definitive human cytosolic localization evidence.
Supporting Evidence:
PMID:14730012
We exclusively found a cytosolic localisation of both endogenous human MK
GO:0005829 cytosol
TAS
Reactome:R-HSA-191380
ACCEPT
Summary: Reactome curator assertion of cytosolic localization for the mevalonate-to-mevalonate-5-phosphate reaction.
Reason: Consistent with the definitive human cytosolic localization evidence, and the Reactome reaction is the MK-catalysed step.
Supporting Evidence:
PMID:14730012
We exclusively found a cytosolic localisation of both endogenous human MK
GO:0005777 peroxisome
IDA NOT
PMID:14730012
Mevalonate kinase is a cytosolic enzyme in humans.
ACCEPT
Summary: NOT|located_in peroxisome β€” direct experimental evidence that human MK is not peroxisomal.
Reason: Correctly captures the negative finding: no peroxisomal localization was detected for human MK by multiple methods, overturning earlier peroxisome proposals. This negation directly refutes the ISS peroxisome annotation.
Supporting Evidence:
PMID:14730012
No indication of a peroxisomal localisation was obtained
GO:0050728 negative regulation of inflammatory response
IMP
PMID:16732551
AA amyloidosis complicating hyperimmunoglobulinemia D with p...
MARK AS OVER ANNOTATED
Summary: Inferred anti-inflammatory role from the autoinflammatory phenotype of mevalonate kinase deficiency (HIDS), cited via an AA amyloidosis case report.
Reason: MK's molecular function is metabolic (kinase); the autoinflammatory HIDS phenotype is a downstream consequence of reduced isoprenoid output, not a direct regulatory activity of MVK in the inflammatory response. The cited reference is a two-patient case report of AA amyloidosis in HIDS and does not demonstrate a direct MK-mediated regulation of inflammation. Retained but flagged as an over-annotation (disease-consequence inference) rather than removed, per policy on experimental (IMP) annotations.
Supporting Evidence:
PMID:16732551
hyperimmunoglobulinemia D with periodic fever syndrome (HIDS)
GO:0004496 mevalonate kinase activity
IMP
PMID:10369261
Mutations in MVK, encoding mevalonate kinase, cause hyperimm...
ACCEPT
Summary: Reduced MK activity in HIDS patient cells demonstrates the enzyme's mevalonate kinase activity via mutational phenotype.
Reason: HIDS mutations reduce MK enzymatic activity, confirming MVK encodes the mevalonate kinase activity; the IMP is well supported.
Supporting Evidence:
PMID:10369261
revealed reduced activities of mevalonate kinase
GO:0005829 cytosol
IDA
PMID:14730012
Mevalonate kinase is a cytosolic enzyme in humans.
ACCEPT
Summary: Direct experimental cytosolic localization of human MK.
Reason: Definitive direct evidence for cytosolic localization; the preferred, specific cellular-component annotation for this protein.
Supporting Evidence:
PMID:14730012
We exclusively found a cytosolic localisation of both endogenous human MK
GO:0004496 mevalonate kinase activity
IDA
PMID:1377680
Molecular cloning of human mevalonate kinase and identificat...
ACCEPT
Summary: Molecular cloning of human MVK and functional expression confirming mevalonate kinase activity; MEVA missense mutation reduces activity.
Reason: Cloning + functional expression established the human enzyme's kinase activity and linked it to mevalonic aciduria.
Supporting Evidence:
PMID:1377680
confirmed that the mutation produced an
GO:0004496 mevalonate kinase activity
IDA
PMID:14730012
Mevalonate kinase is a cytosolic enzyme in humans.
ACCEPT
Summary: Direct measurement of endogenous human MK enzymatic activity in the subcellular-localization study.
Reason: Endogenous human MK activity was assayed (fractionation/permeabilization), confirming the core mevalonate kinase activity in a cytosolic context.
Supporting Evidence:
PMID:14730012
We exclusively found a cytosolic localisation of both endogenous human MK
GO:0006695 cholesterol biosynthetic process
IDA
PMID:1377680
Molecular cloning of human mevalonate kinase and identificat...
KEEP AS NON CORE
Summary: MK function within the cholesterol/isoprene biosynthetic pathway, inferred from the mevalonic aciduria metabolic defect.
Reason: Cholesterol biosynthesis is a valid downstream output of the mevalonate pathway, but MK's committed step precedes the sterol/non-sterol branch point; kept as a legitimate non-core process (the core BP is isopentenyl diphosphate biosynthesis, GO:0019287).
Supporting Evidence:
PMID:1377680
Mevalonic aciduria is the first proposed inherited disorder of the
GO:0008299 isoprenoid biosynthetic process
IDA
PMID:14730012
Mevalonate kinase is a cytosolic enzyme in humans.
ACCEPT
Summary: MK participates in isoprenoid biosynthesis; localization study frames MK within the isoprenoid/cholesterol pathway.
Reason: Valid (broad) biological process for MK; the isoprenoid pathway role is well established.
Supporting Evidence:
PMID:14730012
isoprenoid/cholesterol biosynthesis
GO:0004496 mevalonate kinase activity
IDA
PMID:14680974
Cholesterol biosynthesis is not defective in peroxisome biog...
ACCEPT
Summary: MK enzymatic activity measured directly in fibroblasts (activity present and peroxisome-independent).
Reason: Direct activity measurement of human MK; supports the core kinase function and confirms it does not require peroxisomes.
Supporting Evidence:
PMID:14680974
all enzymes measured are at least as active in
GO:0008299 isoprenoid biosynthetic process
IDA
PMID:14680974
Cholesterol biosynthesis is not defective in peroxisome biog...
ACCEPT
Summary: MK operates in the cholesterol/isoprenoid biosynthetic pathway, independent of peroxisomes.
Reason: Valid biological process; the study measured MK as one of the presqualene-segment cholesterol/isoprenoid enzymes.
Supporting Evidence:
PMID:14680974
cholesterol/isoprenoid biosynthetic

Core Functions

Mevalonate kinase catalyses the ATP- and Mg2+-dependent phosphorylation of (R)-mevalonate to (R)-5-phosphomevalonate, the committed step immediately downstream of HMG-CoA reductase in the mevalonate/isoprenoid pathway.

Supporting Evidence:
  • PMID:9325256
    This stable enzyme is a dimer of 42-kDa subunits
  • file:human/MVK/MVK-uniprot.txt
    Reaction=(R)-mevalonate + ATP = (R)-5-phosphomevalonate + ADP + H(+)

ATP binding: MK binds Mg-ATP as the phosphate-donor co-substrate for the kinase reaction; farnesyl and geranylgeranyl diphosphate compete at this site to provide feedback inhibition.

Molecular Function:
ATP binding
Supporting Evidence:
  • PMID:9392419
    only MKase was inhibited through competitive interaction at the ATP-binding site

Magnesium ion binding: Mg2+ is the required cofactor coordinated with ATP for phosphoryl transfer.

Molecular Function:
magnesium ion binding
Supporting Evidence:
  • file:human/MVK/MVK-uniprot.txt
    Name=Mg(2+); Xref=ChEBI:CHEBI:18420

Mevalonate kinase is a cytosolic enzyme in humans.

Cellular Locations:
Supporting Evidence:
  • PMID:14730012
    We exclusively found a cytosolic localisation of both endogenous human MK

References

Loading supporting content…

Download this section (compressed HTML)

πŸ“š Additional Documentation

Notes

(MVK-notes.md)

Loading supporting content…

Download this section (compressed HTML)

πŸ“„ View Raw YAML

Loading supporting content…

Download this section (compressed HTML)